G. Russo

A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

Flavio Vincenti, B Charpentier, Yves Vanrenterghem et al. · American Journal of Transplantation · 2010 · 946 citations

Medicine, Nephrology, Pharmacology +15

Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)

Antoine Dürrbach, JO Medina Pestana, Thomas C. Pearson et al. · American Journal of Transplantation · 2010 · 565 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT Studies

Christian P. Larsen, Josep M. Grinyó, José Osmar Medina Pestana et al. · Transplantation · 2010 · 171 citations

Medicine, Nephrology, Pharmacotherapy +16

Giroctocogene fitelparvovec gene therapy for severe hemophilia A: 104-week analysis of the phase 1/2 Alta study

Andrew D. Leavitt, Barbara A. Konkle, Kimo C. Stine et al. · Blood · 2023 · 40 citations · Full text

Medicine, Hematology, Pharmacotherapy +12

Updated Follow-up of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (SB-525) Gene Therapy in Adults with Severe Hemophilia a

Andrew D. Leavitt, Barbara A. Konkle, Kimo C. Stine et al. · Blood · 2020 · 23 citations

Medicine, Hematology, Translational Sciences +7